Le Lézard
Classified in: Science and technology
Subjects: Dividend, Stock Sale/Buyback

C.H. Robinson Increases Quarterly Cash Dividend and Share Repurchase Authorization


C.H. Robinson Worldwide, Inc. ("C.H. Robinson") (Nasdaq: CHRW) announced that its Board of Directors today declared an increase to its regular quarterly cash dividend to 55 cents ($0.55) per share from 51 cents ($0.51) per share, payable on January 3, 2022, to shareholders of record on December 13, 2021.

C.H. Robinson has distributed uninterrupted dividends without decline for more than twenty years. As of December 9, 2021, there were approximately 129,471,210 shares outstanding.

In addition, on December 9, 2021, the Board of Directors increased the company's share repurchase authorization by an additional 20 million shares of common stock. C.H. Robinson had approximately 2.1 million shares remaining under its share repurchase authorization, which was authorized by the Board in May 2018. Repurchases may be made from time to time at prevailing prices in the open market or in privately negotiated transactions, subject to market conditions and other factors.

About C.H. Robinson

C.H. Robinson solves logistics problems for companies across the globe and across industries, from the simple to the most complex. With $26 billion in freight under management and 19 million shipments annually, we are one of the world's largest logistics platforms. Our global suite of services accelerates trade to seamlessly deliver the products and goods that drive the world's economy. With the combination of our multimodal transportation management system and expertise, we use our information advantage to deliver smarter solutions for our more than 105,000 customers and 73,000 contract carriers. Our technology is built by and for supply chain experts to bring faster, more meaningful improvements to our customers' businesses. As a responsible global citizen, we are also proud to contribute millions of dollars to support causes that matter to our company, our Foundation and our employees. For more information, visit us at www.chrobinson.com (Nasdaq: CHRW).

Source: C.H. Robinson
CHRW-IR


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 18:57
Tribe Property Technologies Inc. (the "Issuer" or the "Company") , a leading provider of technology-elevated property management solutions, today announced that it expects to complete and file its 2023 Annual Filings (as defined below) on or before...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...



News published on and distributed by: